Isun Pharmasuticals India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.20 M
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2022
About Isun Pharmasuticals India
Isun Pharmasuticals India Private Limited (IPIPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 July 2020 (Four years and six months 18 days old ). Its registered office is in Kannur, Kerala, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Valsan Matathil and Sreeja Kothalil serve as directors at the Company.
Company Details
- Location
Kannur, Kerala, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24290KL2020PTC062918
- Company No.
062918
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Jul 2020
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Isun Pharmasuticals India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Valsan Matathil  | Managing Director | 15-Jul-2020 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sreeja Kothalil | Whole-Time Director | 15-Jul-2020 | Current |
Financial Performance of Isun Pharmasuticals India.
Enhance accessibility to Isun Pharmasuticals India's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Isun Pharmasuticals India?
Unlock access to Isun Pharmasuticals India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Red & Green Infotech LlpValsan Matathil and Sreeja Kothalil are mutual person
- Soorya Insurance Marketing Private Limited
Valsan Matathil and Sreeja Kothalil are mutual person
- Imprint Education Private Limited
Valsan Matathil and Sreeja Kothalil are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Isun Pharmasuticals India?
Isun Pharmasuticals India has a workforce of 0 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Isun Pharmasuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Isun Pharmasuticals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.